Pharmacists in Grosse Pointe Woods, Michigan


11 Pharmacists found in Grosse Pointe Woods
male pharmacist

Andrew Atleski


Pharmacist
922 S Brys Dr, Grosse Pointe Woods, MI 48236
586-291-5988    

female pharmacist

Chioma Nweke, PHARMD


Pharmacist - Oncology
19229 Mack Ave Ste 24, Grosse Pointe Woods, MI 48236
313-884-5522    

male pharmacist

Dayvid Basho


Pharmacist
20460 Mack Ave, Grosse Pointe Woods, MI 48236
313-881-2500    



female pharmacist

Julie Gutmann, RPH


Pharmacist
20460 Mack Ave, Grosse Pointe Woods, MI 48236
313-881-2500    

female pharmacist

Kayleen Kremers Stuhldreer, R.PH.


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
20422 Mack Ave, Grosse Pointe Woods, MI 48236
313-308-1033    

female pharmacist

Kristin Alisa Sandoval


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
20422 Mack Ave, Grosse Pointe Woods, MI 48236
313-308-1033     313-308-1036

female pharmacist

Dr. Mary Miracle, PHARMD


Pharmacist - Oncology
19229 Mack Ave Ste 34, Grosse Pointe Woods, MI 48236
313-647-3245    

male pharmacist

Michael Gerard Lebryk, R.PH


Pharmacist
20853 Mack Ave, Grosse Pointe Woods, MI 48236
313-881-4480     313-881-7449

female pharmacist

Dr. Patricia Ann Camazzola, PHARMD


Pharmacist
911 S Oxford Rd, Grosse Pointe Woods, MI 48236
313-506-9873     313-885-6520

female pharmacist

Dr. Sarah Trevena, PHARMD


Pharmacist
20460 Mack Ave, Grosse Pointe Woods, MI 48236
313-881-2500    

male pharmacist

Dr. Shawn Depcinski, PHARM.D.


Pharmacist - Clinician (PhC)/ Clinical Pharmacy Specialist
19251 Mack Ave Ste 333, Grosse Pointe Woods, MI 48236
313-343-7280     313-343-7277


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.